1
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
287,668
$155.9m8.50%
8.50%
Added Shares held: Q3 2025 253.2k, Q4 2025 252.6k, Q1 2026 264.3k, Q2 2026 287.7k
+23.4k
+23,397
8.8%
2
ABIVAX SA
SPONSORED ADS
ABVX
ABVX
913,880
$121.8m6.64%
6.64%
Reduced Shares held: Q3 2025 426.5k, Q4 2025 657.8k, Q1 2026 934.4k, Q2 2026 913.9k
-20.5k
-20,543
-2.2%
3
ENCOMPASS HEALTH CORP
COM
EHC
EHC
1,026,919
$103.8m5.66%
5.66%
Added Shares held: Q3 2025 0, Q4 2025 106.9k, Q1 2026 194.1k, Q2 2026 1.0m
+832.8k
+832,815
429.1%
4
ENSIGN GROUP INC
COM
ENSG
ENSG
602,079
$96.5m5.26%
5.26%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 14.8k, Q2 2026 602.1k
+587.3k
+587,318
3978.8%
5
VERA THERAPEUTICS INC
CL A
VERA
VERA
2,212,770
$94.9m5.18%
5.18%
Added Shares held: Q3 2025 2.8m, Q4 2025 3.1m, Q1 2026 2.2m, Q2 2026 2.2m
+39.5k
+39,484
1.8%
6
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
1,785,941
$66.5m3.62%
3.62%
Reduced Shares held: Q3 2025 1.2m, Q4 2025 1.4m, Q1 2026 1.8m, Q2 2026 1.8m
-2.1k
-2,075
-0.1%
7
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
2,798,210
$61.2m3.33%
3.33%
Reduced Shares held: Q3 2025 3.5m, Q4 2025 3.3m, Q1 2026 2.9m, Q2 2026 2.8m
-87.4k
-87,412
-3.0%
8
BROOKDALE SR LIVING INC
COM
BKD
BKD
3,396,470
$54.6m2.98%
2.98%
Reduced Shares held: Q3 2025 0, Q4 2025 374.9k, Q1 2026 3.6m, Q2 2026 3.4m
-172.1k
-172,085
-4.8%
9
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
664,684
$52.7m2.87%
2.87%
Added Shares held: Q3 2025 538.7k, Q4 2025 538.2k, Q1 2026 632.1k, Q2 2026 664.7k
+32.6k
+32,584
5.2%
10
NATERA INC
COM
NTRA
NTRA
175,807
$47.7m2.60%
2.60%
Reduced Shares held: Q3 2025 519.6k, Q4 2025 334.5k, Q1 2026 384.7k, Q2 2026 175.8k
-208.9k
-208,906
-54.3%
11
TRAVERE THERAPEUTICS INC
COM
TVTX
TVTX
798,973
$45.4m2.47%
2.47%
Added Shares held: Q3 2025 1.4m, Q4 2025 1.2m, Q1 2026 542.6k, Q2 2026 799.0k
+256.4k
+256,363
47.2%
12
CARETRUST REIT INC
COM
CTRE
CTRE
1,072,015
$43.3m2.36%
2.36%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
13
HCA HEALTHCARE INC
COM
HCA
HCA
98,252
$38.3m2.09%
2.09%
Added Shares held: Q3 2025 111.7k, Q4 2025 95.9k, Q1 2026 79.2k, Q2 2026 98.3k
+19.0k
+19,023
24.0%
14
VAXCYTE INC
COM
PCVX
PCVX
629,952
$36.6m2.00%
2.00%
Reduced Shares held: Q3 2025 1.4m, Q4 2025 1.2m, Q1 2026 924.2k, Q2 2026 630.0k
-294.2k
-294,241
-31.8%
15
LIQUIDIA CORPORATION
COM NEW
LQDA
LQDA
428,652
$34.2m1.86%
1.86%
Reduced Shares held: Q3 2025 486.0k, Q4 2025 509.4k, Q1 2026 677.4k, Q2 2026 428.7k
-248.7k
-248,740
-36.7%
16
COMMUNITY HEALTH SYS INC NEW
COM
CYH
CYH
7,864,575
$26.3m1.43%
1.43%
Reduced Shares held: Q3 2025 7.0m, Q4 2025 7.9m, Q1 2026 8.7m, Q2 2026 7.9m
-812.7k
-812,706
-9.4%
17
GSK PLC
SPONSORED ADR
GSK
GSK
481,833
$25.3m1.38%
1.38%
Reduced Shares held: Q3 2025 2.1m, Q4 2025 2.7m, Q1 2026 1.8m, Q2 2026 481.8k
-1.3m
-1,303,342
-73.0%
18
CHEMED CORP NEW
COM
CHE
CHE
52,523
$24.5m1.33%
1.33%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 31.1k, Q2 2026 52.5k
+21.5k
+21,466
69.1%
19
ELI LILLY & CO
COM
LLY
LLY
20,116
$24.1m1.32%
1.32%
Added Shares held: Q3 2025 0, Q4 2025 10.6k, Q1 2026 19.0k, Q2 2026 20.1k
+1.1k
+1,116
5.9%
20
GERON CORP
COM
GERN
GERN
18,717,422
$24.0m1.31%
1.31%
Reduced Shares held: Q3 2025 12.6m, Q4 2025 17.7m, Q1 2026 18.8m, Q2 2026 18.7m
-117.5k
-117,461
-0.6%
21
VIKING THERAPEUTICS INC
COM
VKTX
VKTX
602,922
$23.5m1.28%
1.28%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 239.1k, Q2 2026 602.9k
+363.8k
+363,812
152.2%
22
OMEGA HEALTHCARE INVS INC
COM
OHI
OHI
483,547
$23.1m1.26%
1.26%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 585.7k, Q2 2026 483.5k
-102.1k
-102,133
-17.4%
23
INSULET CORP
COM
PODD
PODD
148,816
$22.7m1.24%
1.24%
Added Shares held: Q3 2025 45.6k, Q4 2025 74.7k, Q1 2026 143.5k, Q2 2026 148.8k
+5.3k
+5,270
3.7%
24
TENET HEALTHCARE CORP
COM NEW
THC
THC
114,199
$21.4m1.16%
1.16%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 29.5k, Q2 2026 114.2k
+84.7k
+84,687
287.0%
25
UNITEDHEALTH GROUP INC
COM
UNH
UNH
51,145
$21.3m1.16%
1.16%
New Shares held: Q3 2025 62.8k, Q4 2025 60.9k, Q1 2026 0, Q2 2026 51.1k
26
WELLTOWER INC
COM
WELL
WELL
87,312
$19.8m1.08%
1.08%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 181.0k, Q2 2026 87.3k
-93.6k
-93,641
-51.8%
27
BETA BIONICS INC
COM
BBNX
BBNX
1,249,441
$19.6m1.07%
1.07%
Reduced Shares held: Q3 2025 0, Q4 2025 678.3k, Q1 2026 1.4m, Q2 2026 1.2m
-165.4k
-165,397
-11.7%
28
COGENT BIOSCIENCES INC
COM
COGT
COGT
490,235
$19.0m1.03%
1.03%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 490.2k
29
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
1,865,653
$18.7m1.02%
1.02%
Reduced Shares held: Q3 2025 1.4m, Q4 2025 3.0m, Q1 2026 3.0m, Q2 2026 1.9m
-1.2m
-1,174,167
-38.6%
30
MOLINA HEALTHCARE INC
COM
MOH
MOH
80,594
$18.4m1.00%
1.00%
Added Shares held: Q3 2025 9.5k, Q4 2025 45.5k, Q1 2026 32.8k, Q2 2026 80.6k
+47.8k
+47,783
145.6%
31
PENNANT GROUP INC
COM
PNTG
PNTG
460,272
$17.0m0.93%
0.93%
Added Shares held: Q3 2025 38.0k, Q4 2025 294.0k, Q1 2026 312.2k, Q2 2026 460.3k
+148.1k
+148,094
47.4%
32
LTC PPTYS INC
COM
LTC
LTC
420,640
$16.2m0.88%
0.88%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 321.0k, Q2 2026 420.6k
+99.6k
+99,594
31.0%
33
INSMED INC
COM PAR $.01
INSM
INSM
149,209
$15.9m0.87%
0.87%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 149.2k
34
VIRIDIAN THERAPEUTICS INC
COM
VRDN
VRDN
831,142
$15.3m0.83%
0.83%
Added Shares held: Q3 2025 1.9m, Q4 2025 1.8m, Q1 2026 713.3k, Q2 2026 831.1k
+117.9k
+117,873
16.5%
35
BIOMARIN PHARMACEUTICAL INC
COM
BMRN
BMRN
249,607
$14.3m0.78%
0.78%
Added Shares held: Q3 2025 146.6k, Q4 2025 93.7k, Q1 2026 207.8k, Q2 2026 249.6k
+41.8k
+41,839
20.1%
36
AMN HEALTHCARE SVCS INC
COM
AMN
AMN
428,531
$13.9m0.76%
0.76%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 428.5k
37
CELCUITY INC
COM
CELC
CELC
127,931
$13.4m0.73%
0.73%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 127.9k
38
PHARVARIS N V
COM
PHVS
PHVS
386,383
$13.4m0.73%
0.73%
Reduced Shares held: Q3 2025 0, Q4 2025 439.2k, Q1 2026 407.0k, Q2 2026 386.4k
-20.6k
-20,577
-5.1%
39
CYTOMX THERAPEUTICS INC
COM
CTMX
CTMX
3,558,497
$13.3m0.73%
0.73%
Added Shares held: Q3 2025 0, Q4 2025 2.5m, Q1 2026 3.2m, Q2 2026 3.6m
+370.0k
+369,983
11.6%
40
HUMANA INC
COM
HUM
HUM
31,171
$12.4m0.67%
0.67%
New Shares held: Q3 2025 16.7k, Q4 2025 32.5k, Q1 2026 0, Q2 2026 31.2k
41
XENON PHARMACEUTICALS INC
COM
XENE
XENE
196,532
$11.9m0.65%
0.65%
Added Shares held: Q3 2025 0, Q4 2025 231.4k, Q1 2026 129.6k, Q2 2026 196.5k
+67.0k
+66,958
51.7%
42
CORVUS PHARMACEUTICALS INC
COM
CRVS
CRVS
747,994
$11.2m0.61%
0.61%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 748.0k
43
ASCENDIS PHARMA A/S
ORD SHS
ASND
ASND
41,621
$11.1m0.61%
0.61%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 41.6k
44
BRUKER CORP
COM
BRKR
BRKR
182,894
$11.0m0.60%
0.60%
Added Shares held: Q3 2025 687.1k, Q4 2025 783.8k, Q1 2026 117.0k, Q2 2026 182.9k
+65.9k
+65,881
56.3%
45
MODERNA INC
COM
MRNA
MRNA
152,122
$10.7m0.58%
0.58%
Reduced Shares held: Q3 2025 0, Q4 2025 267.8k, Q1 2026 159.7k, Q2 2026 152.1k
-7.6k
-7,586
-4.8%
46
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
196,302
$10.5m0.57%
0.57%
Added Shares held: Q3 2025 166.4k, Q4 2025 127.6k, Q1 2026 138.0k, Q2 2026 196.3k
+58.3k
+58,266
42.2%
47
DEFINIUM THERAPEUTICS INC
COM SHS
DFTX
DFTX
217,185
$10.2m0.56%
0.56%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 160.7k, Q2 2026 217.2k
+56.5k
+56,462
35.1%
48
COMPASS PATHWAYS PLC
SPONSORED ADS
CMPS
CMPS
672,825
$9.5m0.52%
0.52%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 677.9k, Q2 2026 672.8k
-5.1k
-5,099
-0.8%
49
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
NAMS
NAMS
275,471
$9.3m0.51%
0.51%
Reduced Shares held: Q3 2025 488.6k, Q4 2025 420.8k, Q1 2026 285.8k, Q2 2026 275.5k
-10.3k
-10,293
-3.6%
50
REVVITY INC
COM
RVTY
RVTY
83,624
$9.3m0.51%
0.51%
Reduced Shares held: Q3 2025 394.3k, Q4 2025 162.8k, Q1 2026 84.9k, Q2 2026 83.6k
-1.2k
-1,230
-1.4%
51
PALISADE BIO INC
COM
PALI
PALI
4,182,785
$8.7m0.48%
0.48%
Reduced Shares held: Q3 2025 0, Q4 2025 5.4m, Q1 2026 5.0m, Q2 2026 4.2m
-804.7k
-804,714
-16.1%
52
ARDELYX INC
COM
ARDX
ARDX
1,678,345
$8.6m0.47%
0.47%
Reduced Shares held: Q3 2025 1.4m, Q4 2025 1.7m, Q1 2026 2.2m, Q2 2026 1.7m
-551.1k
-551,101
-24.7%
53
MINERALYS THERAPEUTICS INC
COM
MLYS
MLYS
309,689
$8.4m0.46%
0.46%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 309.7k
54
RELAY THERAPEUTICS INC
COM
RLAY
RLAY
434,314
$8.1m0.44%
0.44%
Added Shares held: Q3 2025 479.1k, Q4 2025 489.1k, Q1 2026 270.7k, Q2 2026 434.3k
+163.6k
+163,609
60.4%
55
NOVO-NORDISK A S
ADR
NVO
NVO
169,227
$8.1m0.44%
0.44%
New Shares held: Q3 2025 217.7k, Q4 2025 0, Q1 2026 0, Q2 2026 169.2k
56
BIOHAVEN LTD
COM
BHVN
BHVN
515,804
$7.7m0.42%
0.42%
New Shares held: Q3 2025 0, Q4 2025 145.4k, Q1 2026 0, Q2 2026 515.8k
57
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
58,504
$7.2m0.39%
0.39%
New Shares held: Q3 2025 0, Q4 2025 53.0k, Q1 2026 0, Q2 2026 58.5k
58
ENLIVEN THERAPEUTICS INC
COM
ELVN
ELVN
136,631
$6.9m0.38%
0.38%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 136.6k
59
REPLIMUNE GROUP INC
COM
REPL
REPL
590,252
$6.5m0.36%
0.36%
Added Shares held: Q3 2025 60.0k, Q4 2025 0, Q1 2026 334.9k, Q2 2026 590.3k
+255.4k
+255,391
76.3%
60
LB PHARMACEUTICALS INC
COM SHS
LBRX
LBRX
183,663
$6.0m0.32%
0.32%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 100.2k, Q2 2026 183.7k
+83.5k
+83,465
83.3%
61
BEAM THERAPEUTICS INC
COM
BEAM
BEAM
166,289
$5.7m0.31%
0.31%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 166.3k
62
NATIONAL HEALTH INVS INC
COM
NHI
NHI
70,673
$5.4m0.29%
0.29%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 70.7k
63
ULTRAGENYX PHARMACEUTICAL IN
COM
RARE
RARE
154,130
$5.1m0.28%
0.28%
Added Shares held: Q3 2025 0, Q4 2025 317.2k, Q1 2026 62.6k, Q2 2026 154.1k
+91.6k
+91,555
146.3%
64
PACS GROUP INC
COM SHS
PACS
PACS
117,441
$5.0m0.27%
0.27%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 117.4k
65
EQUILLIUM INC
COM
EQ
EQ
1,520,824
$4.9m0.27%
0.27%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.5m, Q2 2026 1.5m
+21.8k
+21,831
1.5%
66
ANAPTYSBIO INC
COM
ANAB
ANAB
69,983
$4.7m0.26%
0.26%
Added Shares held: Q3 2025 0, Q4 2025 120.9k, Q1 2026 27.1k, Q2 2026 70.0k
+42.9k
+42,894
158.3%
67
NATIONAL HEALTHCARE CORP
COM
NHC
NHC
22,116
$4.7m0.25%
0.25%
New Shares held: Q3 2025 0, Q4 2025 28.6k, Q1 2026 0, Q2 2026 22.1k
68
EYEPOINT PHARMACEUTICALS INC
COM NEW
EYPT
EYPT
297,735
$4.3m0.23%
0.23%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 297.7k
69
SONIDA SENIOR LIVING INC
COM
SNDA
SNDA
102,624
$4.2m0.23%
0.23%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 28.4k, Q2 2026 102.6k
+74.2k
+74,187
260.9%
70
GLAUKOS CORP
COM
GKOS
GKOS
29,343
$4.1m0.22%
0.22%
Reduced Shares held: Q3 2025 0, Q4 2025 147.5k, Q1 2026 60.2k, Q2 2026 29.3k
-30.9k
-30,871
-51.3%
71
AGILON HEALTH INC
COM NEW
AGL
AGL
37,792
$4.1m0.22%
0.22%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 176.6k, Q2 2026 37.8k
-138.8k
-138,796
-78.6%
72
ARCUTIS BIOTHERAPEUTICS INC
COM
ARQT
ARQT
135,355
$3.5m0.19%
0.19%
Reduced Shares held: Q3 2025 111.5k, Q4 2025 434.6k, Q1 2026 576.6k, Q2 2026 135.4k
-441.2k
-441,225
-76.5%
73
TARSUS PHARMACEUTICALS INC
COM
TARS
TARS
55,710
$3.5m0.19%
0.19%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 55.7k
74
ALTO NEUROSCIENCE INC
COM SHS
ANRO
ANRO
128,286
$3.4m0.18%
0.18%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 125.2k, Q2 2026 128.3k
+3.1k
+3,118
2.5%
75
ARS PHARMACEUTICALS INC
COM
SPRY
SPRY
377,007
$3.0m0.16%
0.16%
Added Shares held: Q3 2025 976.5k, Q4 2025 251.6k, Q1 2026 136.2k, Q2 2026 377.0k
+240.8k
+240,772
176.7%
76
INFLARX NV
COM
IFRX
IFRX
1,304,069
$2.9m0.16%
0.16%
Reduced Shares held: Q3 2025 1.7m, Q4 2025 1.8m, Q1 2026 1.8m, Q2 2026 1.3m
-454.5k
-454,504
-25.9%
77
INTUITIVE SURGICAL INC
COM NEW
ISRG
ISRG
7,241
$2.9m0.16%
0.16%
Reduced Shares held: Q3 2025 14.4k, Q4 2025 18.1k, Q1 2026 11.1k, Q2 2026 7.2k
-3.9k
-3,878
-34.9%
78
ALECTOR INC
COM
ALEC
ALEC
1,423,873
$2.9m0.16%
0.16%
Added Shares held: Q3 2025 1.5m, Q4 2025 1.0m, Q1 2026 1.4m, Q2 2026 1.4m
+72.8k
+72,767
5.4%
79
VOR BIOPHARMA INC
COM NEW
VOR
VOR
149,681
$2.8m0.15%
0.15%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 149.7k
80
DESIGN THERAPEUTICS INC
COM
DSGN
DSGN
190,000
$2.7m0.15%
0.15%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 190.0k
81
KARYOPHARM THERAPEUTICS INC
COM NEW
KPTI
KPTI
276,174
$2.7m0.15%
0.15%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 276.2k, Q2 2026 276.2k
82
PMV PHARMACEUTICALS INC
COM
PMVP
PMVP
1,890,904
$2.5m0.14%
0.14%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.3m, Q2 2026 1.9m
-457.5k
-457,456
-19.5%
83
CONTINEUM THERAPEUTICS INC
CL A
CTNM
CTNM
148,017
$2.4m0.13%
0.13%
Added Shares held: Q3 2025 134.6k, Q4 2025 137.5k, Q1 2026 146.4k, Q2 2026 148.0k
+1.6k
+1,606
1.1%
84
EVOMMUNE INC
COM SHS
EVMN
EVMN
174,460
$2.3m0.13%
0.13%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 54.7k, Q2 2026 174.5k
+119.8k
+119,780
219.1%
85
AMARIN CORP PLC
SPONSORED ADR
AMRN
AMRN
145,296
$2.3m0.13%
0.13%
Reduced Shares held: Q3 2025 167.3k, Q4 2025 172.2k, Q1 2026 147.7k, Q2 2026 145.3k
-2.4k
-2,419
-1.6%
86
SPRUCE BIOSCIENCES INC
COM NEW
SPRB
SPRB
40,000
$2.2m0.12%
0.12%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 40.0k
87
REPLIGEN CORP
COM
RGEN
RGEN
14,401
$2.0m0.11%
0.11%
Reduced Shares held: Q3 2025 105.1k, Q4 2025 0, Q1 2026 120.8k, Q2 2026 14.4k
-106.4k
-106,384
-88.1%
88
INVIVYD INC
COM
IVVD
IVVD
2,237,015
$2.0m0.11%
0.11%
Reduced Shares held: Q3 2025 2.0m, Q4 2025 2.1m, Q1 2026 2.3m, Q2 2026 2.2m
-39.3k
-39,334
-1.7%
89
PROQR THRAPEUTICS N V
SHS EURO
PRQR
PRQR
1,022,265
$1.9m0.10%
0.10%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
90
GRACE THERAPEUTICS INC
COM
GRCE
GRCE
772,900
$1.8m0.10%
0.10%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 756.6k, Q2 2026 772.9k
+16.3k
+16,300
2.1%
91
ANTERIS TECHNOLOGIES GLOBAL
COM
AVR
AVR
166,229
$1.6m0.09%
0.09%
Reduced Shares held: Q3 2025 500.0k, Q4 2025 500.0k, Q1 2026 401.2k, Q2 2026 166.2k
-235.0k
-234,958
-58.6%
92
VIR BIOTECHNOLOGY INC
COM
VIR
VIR
156,636
$1.6m0.09%
0.09%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 250.0k, Q2 2026 156.6k
-93.4k
-93,364
-37.4%
93
EDITAS MEDICINE INC
COM
EDIT
EDIT
458,809
$1.5m0.08%
0.08%
Added Shares held: Q3 2025 0, Q4 2025 290.9k, Q1 2026 290.9k, Q2 2026 458.8k
+167.9k
+167,890
57.7%
94
AADI BIOSCIENCE INC
COM
WHWK
WHWK
303,306
$1.4m0.08%
0.08%
Reduced Shares held: Q3 2025 0, Q4 2025 260.3k, Q1 2026 306.8k, Q2 2026 303.3k
-3.5k
-3,494
-1.1%
95
BIO-TECHNE CORP
COM
TECH
TECH
19,308
$1.4m0.07%
0.07%
Reduced Shares held: Q3 2025 591.5k, Q4 2025 377.4k, Q1 2026 125.9k, Q2 2026 19.3k
-106.6k
-106,588
-84.7%
96
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
6,943
$1.3m0.07%
0.07%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.9k
97
SAVARA INC
COM
SVRA
SVRA
204,428
$1.3m0.07%
0.07%
Reduced Shares held: Q3 2025 0, Q4 2025 170.2k, Q1 2026 384.3k, Q2 2026 204.4k
-179.8k
-179,836
-46.8%
98
SURROZEN INC
COM NEW
SRZN
SRZN
47,777
$1.2m0.07%
0.07%
Reduced Shares held: Q3 2025 77.0k, Q4 2025 95.3k, Q1 2026 58.6k, Q2 2026 47.8k
-10.8k
-10,847
-18.5%
99
INOVIO PHARMACEUTICALS INC
COM SHS
INO
INO
1,035,360
$1.1m0.06%
0.06%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0m, Q2 2026 1.0m
100
PLIANT THERAPEUTICS INC
COM
PLRX
PLRX
891,425
$1.0m0.06%
0.06%
Unchanged Shares held: Q3 2025 824.6k, Q4 2025 842.0k, Q1 2026 891.4k, Q2 2026 891.4k